AstraZeneca today announced it has entered into a settlement agreement in its Nexium patent infringement litigation against Ranbaxy Laboratories Ltd. and its affiliates (“Ranbaxy†). The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results